Reports Q1 revenue $54.76B, consensus $54.76B. “With strong first quarter results and an improved outlook for the year, we are continuing our operating momentum into fiscal 2024,” said Jason Hollar, CEO of Cardinal Health. “In Q1, we delivered significant profit growth in both the Pharmaceutical and Medical segments, which along with our favorable capital structure and opportunistic capital deployment, gives us confidence to raise fiscal 2024 non-GAAP EPS guidance. Across the enterprise, we continue to prioritize focused execution to best serve our customers and create value for our shareholders.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CAH:
- Options Volatility and Implied Earnings Moves Today, November 03, 2023
- Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
- Notable companies reporting before tomorrow’s open
- CAH Upcoming Earnings Report: What to Expect?
- Cardinal Health price target lowered to $95 from $100 at Evercore ISI